Hello

Hadja Simboro is a biomedical researcher and public health advocate specializing in translational oncology and inclusive cancer prevention. She holds a Specialized Master in Experimental Biomedical Research at the University of Fribourg, Switzerland, with a focus on Infection, Inflammation & Cancer. Her academic and research work centers on molecular diagnostics, biomarker development, and the use of cutting-edge technologies such as DNA-origami biosensors and extracellular vesicles for cancer detection and targeted therapy.

​

Hadja’s scientific journey spans three countries—Burkina Faso, France, and Switzerland—giving her a unique cross-cultural lens on healthcare disparities and cancer education. She began her medical studies in Ouagadougou, continued in Montpellier, and transitioned into biomedical research in Fribourg, where she earned her Bachelor’s degree. Her research contributions include developing nanoscale biosensors for breast cancer mRNA detection and investigating extracellular vesicles as drug delivery platforms, presented at international conferences such as Graubünden forscht and LS2 Annual Meeting.

​

Beyond the lab, Hadja is deeply committed to community engagement. She has served as a youth ambassador for Burkina Faso in Switzerland, coordinated public health screenings, and led science communication initiatives targeting underserved populations. At ACO, she assists coordination of programs that promote cancer awareness, early detection, and equitable access to care across African communities and diaspora populations.

​

Fluent in French and English, Hadja work bridges science and society, advancing ACO’s mission to reduce cancer burden through culturally responsive and evidence-based strategies.